stemmacolore
Cerca

Challenging the role of chemotherapy in HER2 positive early breast cancer: PI3KCA pathways alteration and response to neoadjuvant pertuzumab-trastuzumab plus letrozole or paclitaxel in Hormone Receptor positive HER2 positive breast cancer patients.

Challenging the role of chemotherapy in HER2 positive early breast cancer: PI3KCA pathways alteration and response to neoadjuvant pertuzumab-trastuzumab plus letrozole or paclitaxel in Hormone Receptor positive HER2 positive breast cancer patients.

Stato

aperto

Copertura

Nazionale

Tipologia

Ricerca di base/clinica

Ruolo di capofila/partner

Partner

Unità Operativa

UOC Oncologia 2

Ente finanziatore

Ministero della Salute

Principal Investigator

Prof.ssa Valentina Guarneri

Anno di finanziamento

2016
Torna in alto